E S Molloy

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system
    E S Molloy
    Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ann Rheum Dis 67:1732-5. 2008
  2. ncbi Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up
    E S Molloy
    Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44106, USA
    Ann Rheum Dis 67:1567-9. 2008
  3. ncbi Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Eamonn S Molloy
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Autoimmun Rev 8:144-6. 2008
  4. ncbi Therapy: Targeted but not trouble-free: efalizumab and PML
    Eamonn S Molloy
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Nat Rev Rheumatol 5:418-9. 2009
  5. ncbi Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
    Eamonn S Molloy
    Fasenmeyer Center for Clinical Immunology, Department of Rheumatic and Immunology Diseases, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Arthritis Rheum 60:3761-5. 2009
  6. ncbi Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies
    L H Calabrese
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Ann Rheum Dis 67:iii64-5. 2008
  7. ncbi Arteriovenous malformation of the brain mimicking primary central nervous system vasculitis
    J Hernandez-Rodriguez
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Scand J Rheumatol 37:481-4. 2008
  8. ncbi An unusual case of Behçet's syndrome: triggered by typhoid vaccination?
    E S Molloy
    Department of Rheumatology, Mater Misericordiae Hospital, Dublin, Ireland
    Clin Exp Rheumatol 22:S71-4. 2004

Collaborators

Detail Information

Publications8

  1. ncbi Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system
    E S Molloy
    Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ann Rheum Dis 67:1732-5. 2008
    ..To describe the occurrence of mass lesions (ML) in primary angiitis of the central nervous system (PACNS) and assess the utility of diagnostic testing and treatment...
  2. ncbi Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up
    E S Molloy
    Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44106, USA
    Ann Rheum Dis 67:1567-9. 2008
    ..To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive therapies...
  3. ncbi Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Eamonn S Molloy
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Autoimmun Rev 8:144-6. 2008
    ..The mechanism of this putative predisposition of SLE patients to the development of PML remains unexplained...
  4. ncbi Therapy: Targeted but not trouble-free: efalizumab and PML
    Eamonn S Molloy
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Nat Rev Rheumatol 5:418-9. 2009
    ..This event highlights an urgent need for greater awareness and research into the screening, diagnosis and treatment of this potentially fatal disease in patients undergoing immunosuppressive therapy for chronic inflammatory disorders...
  5. ncbi Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
    Eamonn S Molloy
    Fasenmeyer Center for Clinical Immunology, Department of Rheumatic and Immunology Diseases, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Arthritis Rheum 60:3761-5. 2009
    ..The aim of this study was to generate a national estimate of the frequency of PML among patients with rheumatic diseases...
  6. ncbi Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies
    L H Calabrese
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Ann Rheum Dis 67:iii64-5. 2008
    ..In particular, rheumatologists need to be vigilant and pursue the diagnosis of PML in all patients with unexplained neurological signs or symptoms with clinical and MRI findings compatible with the diagnosis...
  7. ncbi Arteriovenous malformation of the brain mimicking primary central nervous system vasculitis
    J Hernandez-Rodriguez
    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Scand J Rheumatol 37:481-4. 2008
    ....
  8. ncbi An unusual case of Behçet's syndrome: triggered by typhoid vaccination?
    E S Molloy
    Department of Rheumatology, Mater Misericordiae Hospital, Dublin, Ireland
    Clin Exp Rheumatol 22:S71-4. 2004
    ..As bacterial antigens have been proposed as potential triggers for the onset of BS, it is possible that the syndrome was precipitated by typhoid vaccination in this patient...